Fibroblast growth factor 21 and thyroid hormone show mutual regulatory dependency but have independent actions in vivo

Endocrinology

Volumn 155, Issue 5, 2014, Pages 2031-2040

  Domouzoglou, Eleni M ^a   Fisher, Ffolliott Martin ^a   Astapova, Inna ^a   Fox, Elliott C ^a   Kharitonenkov, Alexei ^b   Flier, Jeffrey S ^a   Hollenberg, Anthony N ^a   Maratos Flier, Eleftheria ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FIBROBLAST GROWTH FACTOR 21; LIOTRIX; LIPID; MALATE DEHYDROGENASE (DECARBOXYLATING); THYROID HORMONE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 1;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BROWN ADIPOSE TISSUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DOWN REGULATION; ENERGY EXPENDITURE; FAT MASS; FOOD INTAKE; GENE CONTROL; GENE EXPRESSION; HYPOTHYROIDISM; IN VIVO STUDY; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPOGENESIS; LIVER; LIVER WEIGHT; MALE; METABOLITE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA PURIFICATION; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WESTERN BLOTTING;

ADIPOSE TISSUE, BROWN; ANIMALS; ENERGY METABOLISM; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HORMONE REPLACEMENT THERAPY; HYPERLIPIDEMIAS; HYPERTHYROIDISM; HYPOTHYROIDISM; LIPID METABOLISM; LIPOTROPIC AGENTS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; RECOMBINANT PROTEINS; THYROXINE; TRIIODOTHYRONINE;

EID: 84899449747     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1902     Document Type: Article

References (27)

1. Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115:1627-1635.
2. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos- Flier E. Hepatic fibroblast groWTh factor 21 is regulated by PPARα and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007;5:426-437.
3. Fisher FM, Estall JL, Adams AC, et al. Integrated regulation of hepatic metabolism by fibroblast groWTh factor 21 (FGF21) in vivo. Endocrinology. 2011;152:2996-3004.
4. Fisher FM, Kleiner S, Douris N, et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012;26:271-281.
5. van Marken Lichtenbelt W. Brown adipose tissue and the regulation of nonshivering thermogenesis. Curr Opin Clin Nutr Metab Care. 2012;15:547-552.
6. Chartoumpekis DV, Habeos IG, Ziros PG, Psyrogiannis AI, Kyriazopoulou VE, Papavassiliou AG. Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Mol Med. 2011;17:736-740.
7. Coskun T, Bina HA, Schneider MA, Dunbar JD, Hu CC, Chen Y, Moller DE, Kharitonenkov A. Fibroblast groWTh factor 21 corrects obesity in mice. Endocrinology. 2008;149:6018-6027.
8. Xu J, Lloyd DJ, Hale C, et al. Fibroblast groWTh factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes. 2009;58:250-259.
9. Badman MK, Koester A, Flier JS, Kharitonenkov A, Maratos-Flier E. Fibroblast groWTh factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology. 2009;150:4931-4940.
10. Dushay J, Chui PC, Gopalakrishnan GS, et al. Increased fibroblast groWTh factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology. 2010;139:456-463.
11. Cuevas-Ramos D, Almeda-Valdes P, Gómez-Pérez FJ, et al. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast groWTh factor 21 levels. Eur J Endocrinol. 2010;163:469-477.
12. Zhang X, Yeung DC, Karpisek M, Stejskal D, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes. 2008;57:1246-1253.
13. Mraz M, Bartlova M, Lacinova Z, et al. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin Endocrinol (Oxf). 2009;71:369-375.
14. Adams AC, Astapova I, Fisher FM, et al. Thyroid hormone regulates hepatic expression of fibroblast groWTh factor 21 in a PPARα dependent manner. J Biol Chem. 2010;285:14078-14082.
15. Klieverik LP, Coomans CP, Endert E, et al. Thyroid hormone effects on whole-body energy homeostasis and tissue-specific fatty acid uptake in vivo. Endocrinology. 2009;150:5639-5648.
16. Oppenheimer JH, Schwartz HL, Lane JT, Thompson MP. Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat. J Clin Invest. 1991;87:125-132.
17. Freake HC, Oppenheimer JH. Thermogenesis and thyroid function. Annu Rev Nutr. 1995;15:263-291.
18. Harun-Or-Rashid M, Asai M, Sun XY, Hayashi Y, Sakamoto J, Murata Y. Effect of thyroid statuses on sodium/iodide symporter (NIS) gene expression in the extrathyroidal tissues in mice. Thyroid Res. 2010;3:3.
19. Hayashi K, Akiba Y, Tomita Y, Matsumoto T. The concerted effects of thyroid function and dietary protein on groWTh and protein metabolism in mice at different groWTh stages. J Nutr Sci Vitaminol (Tokyo). 1984;30:235-244.
20. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497-509.
21. Zhao S, Fernald RD. Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol. 2005;12:1047-1064.
22. Irrcher I, Adhihetty PJ, Sheehan T, Joseph AM, Hood DA. PPARγ coactivator-1α expression during thyroid hormone- and contractile activity-induced mitochondrial adaptations. Am J Physiol Cell Physiol. 2003;284:C1669-C1677.
23. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463-468.
24. Maia AL, Goemann IM, Meyer EL, Wajner SM. Deiodinases: the balance of thyroid hormone: type 1 iodothyronine deiodinase in human physiology and disease. J Endocrinol. 2011;209:283-297.
25. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest. 2005;115:2524-2533.
26. Laurberg P, Vestergaard H, Nielsen S, et al. Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. J Clin Endocrinol Metab. 2007;92:2149-2156.
27. Blennemann B, Leahy P, Kim TS, Freake HC. Tissue-specific regulation of lipogenic mRNAs by thyroid hormone. Mol Cell Endocrinol. 1995;110:1-8.